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Abstract
The number of germ cells reaches the maximum just prior to entry into meiosis, yet decreases dramatically by a few days after birth in
the female mouse, rat, and human. Previous studies have reported a major loss at the pachytene stage of meiotic prophase during fetal
development, leading to the hypothesis that chromosomal pairing abnormalities may be a signal for oocyte death. However, the identification
as well as the quantification of germ cells in these studies have been questioned. A recent study using Mouse Vasa Homologue (MVH) as
a germ cell marker reached a contradictory conclusion claiming that oocyte loss occurs in the mouse only after birth. In the present study,
we established a new method to quantify murine germ cells by using Germ Cell Nuclear Antigen-1 (GCNA-1) as a germ cell marker.
Comparison of GCNA-1 and MVH immunolabeling revealed that the two markers identify the same population of germ cells. However,
nuclear labeling of GCNA-1 was better suited for counting germ cells in histological sections as well as for double labeling with the antibody
against synaptonemal complex (SC) proteins in chromosome spreading preparations. The latter experiment demonstrated that the majority
of GCNA-1-labeled cells entered and progressed through meiotic prophase during fetal development. The number of GCNA-1-positive cells
in the ovary was estimated by counting the labeled cells retained in chromosome spreading preparations and also in histological sections
by using the ratio estimation method. Both methods demonstrated a continuous decline in the number of GCNA-1-labeled cells during fetal
development when the oocytes progress through meiotic prophase. These observations suggest that multiple causes are responsible for
oocyte elimination.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Since female germ cells only enter meiosis during fetal
life, the initial endowment of oocytes is a limiting factor of
the reproductive life span. Moreover, the oocyte population
is continuously reduced throughout reproductive life, leav-
ing only a small percentage of the initial oocyte endowment
available for ovulation and fertilization. The cause as well
as the biological significance of oocyte elimination remains
largely unknown (reviewed by Tilly, 2001).
Classical studies have shown a major loss of mammalian
oocytes occuring before birth (Beaumont and Mandl, 1962;
Baker, 1963; Burgoyne and Baker, 1985). The number of rat
oocytes, identified by morphological criteria, was shown to
decrease by two-thirds from the onset of meiosis to 2 days
after birth, when the majority of oocytes become arrested at
the end of meiotic prophase (Beaumont and Mandl, 1962).
Light and electron microscope studies revealed three dis-
tinct morphological features of degenerating germ cells in
the ovary (Beaumont and Mandl, 1962; Franchi and Mandl,
1962). The first, termed “atretic divisions,” denotes the
oogonia that appear to be in mitotic metaphase while lack-
ing visible spindles. The second, termed “Z cells,” are the
oocytes that appear to be in meiotic prophase with abnormal
chromosome condensation and eosinophilic cytoplasm. The
third denotes the oocytes that have the nuclear configuration
of diplotene stage but with somewhat abnormal chromo-
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some condensation and crinkling of the nuclear membrane.
Analogous studies in human ovaries have demonstrated
similar morphological features of degenerating oogonia and
oocytes and a reduction in the oocyte population in fetal life
was estimated to be more than 70% (Baker, 1963; Baker and
Franchi, 1967).
In the mouse ovary, several authors have noted degen-
erating oogonia, a significant number of degenerating
pachytene oocytes, and degenerating diplotene oocytes (Bo-
rum, 1961; Bakken and McClanahan, 1978). More recent
studies with the electron microscope have demonstrated the
oogonia arrested in mitotic metaphase but lacking spindles
(Wartenberg et al., 2001). Silver staining of air-dried oo-
cytes has demonstrated that 25% of pachytene oocytes have
gaps in synaptonemal complex (SC) regions, interpreted as
a sign of degeneration (Speed, 1982). The change in the
total oocyte population throughout ovarian development
was not examined in these studies. Burgoyne and Baker
(1985) have shown a sharp decline in the germ cell popu-
lation in prenatal, as well as neonatal, mouse ovaries. How-
ever, their morphological criteria for defining germ cells are
unclear. Pepling and Spradling (2001) have recently used an
antibody against Mouse Vasa Homologue (MVH) to iden-
tify the oocyte and reported that the decrease in the oocyte
population is limited to the neonatal period, between 1 and
2 days after birth. This finding contradicts the previous
studies, as well as the morphological observations of de-
generating oocytes in the fetal mouse ovary. Three expla-
nations are conceivable. First, the fate of oocytes may be
different between the mouse and other mammalian species.
Second, the anti-MVH antibody may recognize a population
of cells that differ from the “oocytes” defined in the earlier
morphological studies. Since the morphological criteria for
identifying an oocyte under the light microscope relies on
nuclear condensation, it is possible that errors could have
been made in defining oocytes. For example, germ cells not
in meiosis may be excluded, whereas somatic cells in mi-
totic metaphase may be included as oocytes. As well, de-
generating cells may have been counted as oocytes. Third,
the estimation method used by Pepling and Spradling may
not have fully represented the total population of MVH
labeled cells. As a single “representative” section was
counted in each ovary, bias may have been imposed in
choosing the section, or counting one section may not rep-
resent the entire ovary.
The timing of major germ cell loss during ovarian de-
velopment is critical for judging the causes of germ cell
elimination. Indeed, the hypotheses that have been proposed
to explain germ cell elimination point toward its occurrence
during discrete developmental periods. First, limited
amounts of trophic factors may permit the survival of only
a fraction of germ cells. Cytokines and growth factors, such
as leukemia inhibitory factor (LIF), retinoic acid (RA), and
stem cell factor (SCF), have been shown to prevent loss of
germ cells in culture (Godin et al., 1991; Matsui et al., 1991;
Resnick et al., 1992; Dolci et al., 1993; Pesce et al., 1993;
Koshimizu et al., 1995; Morita and Tilly, 1999). Further-
more, in vivo roles for mast cell growth factor (MGF 
SCF) and its receptors have been confirmed by germ cell
deficiency in their respective mutant mice (Mintz and Rus-
sell, 1957; Chabot et al., 1988; Huang et al., 1990; Zsebo et
al., 1990; Brannan et al., 1991). These trophic factors likely
influence the oocyte populations equally at various stages of
meiotic prophase. Second, germ cells with telomere dys-
function may be recognized at the onset of meiosis and
thereby eliminated. It has recently been found that, in late
generations of telomerase-deficient mice, the proportion of
germ cells with dysfunctional telomeres, relative to that of
somatic cells, drops after the onset of meiosis (Hemann et
al., 2001). Third, errors in chromosome pairing during mei-
otic prophase may trigger oocyte elimination. This hypoth-
esis has been proposed because morphological features of
degenerating oocytes have often been seen when the major-
ity of oocytes reach the pachytene stage of meiotic prophase
(Speed, 1982, 1988; Dietrich and Mulder, 1983; Mittwoch
and Mahadevaiah, 1992). Furthermore, various mutations of
genes involved in homologous pairing and DNA repair
block the progress of meiotic prophase (Baker et al., 1996;
Edelmann et al., 1996; 1999; Pittman et al., 1998; Kneitz et
al., 2000). In these cases, a major oocyte loss must follow
the peak of pachytene stage (Burgoyne and Baker, 1985;
Burgoyne et al., 1985). Finally, the massive reduction in
oocytes may serve a more altruistic purpose. It has been
proposed that the dying oocytes may play an important role
by donating their cytoplasmic components, such as mito-
chondria, to the surviving oocytes within a cyst (Pepling and
Fig. 1. Comparison of GCNA-1 and MVH immunolabeling in histological sections (A–F) and dissociated cells (G–L) from ovaries at DOB. (A) An ovarian
section labeled with the anti-GCNA-1 antibody. The labeled cells are concentrated at the periphery and scarce in the central region. Scale bar, 100 m. (B,
C) High magnification of the section shown in (A), dually stained with DAPI (B) and with the anti-GCNA-1 antibody (C). The cells showing morphological
characteristics of oocytes with DAPI staining (arrowheads in B) are labeled for GCNA-1 in the nucleus (arrowheads in C). (D) The adjacent section of that
shown in (A), labeled with the anti-MVH antibody. Distribution of the MVH labeled cells is similar to that of the GCNA-1-labeled cells. Scale bar, 100 m.
(E, F) High magnification of the section shown in (D), dually stained with DAPI (E) and with the anti-MVH antibody (F). The cells showing morphological
characteristics of oocytes with DAPI staining (arrowheads in E) are labeled for MVH in the cytoplasm (arrowheads in F). Scale bar, 25 m (also for B, C,
and E). (G) Dissociated ovarian cells labeled with the anti-GCNA-1 antibody. The labeling is localized in the nucleus. (H) The ovarian cells shown in (G),
labeled with the anti-MVH antibody. Note two populations of MVH-labeled cells. Those labeled exclusively in the cytoplasm are also labeled for GCNA-1
(G), whereas those labeled in the nucleus (arrowhead), as identified by DAPI staining (data not shown), are negative for GCNA-1. (I) Overlay of (G) and
(H). GCNA-1-labeled cells in (G) overlap only with the MVH-labeled cells in the cytoplasm in (H). Scale bar, 50 m (also for G and H). (J) An ovarian
cell labeled with the anti-GCNA-1 antibody in the nucleus shown at a high magnification. (K) The same cell shown in (J) labeled with the anti-MVH antibody.
The cytoplasm is evenly labeled. (L) Overlay of (J) and (K). Scale bar, 10 m (also for J and K).
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Spradling, 2001). This hypothesis is based on the observa-
tion that a major loss of oocytes occurs after birth, when
oocyte cysts break down into individual cells.
The present study aimed to establish a reliable new
method to quantify murine oocytes and to determine the
gestational age and meiotic prophase stage at which major
oocyte loss occurs. First, we compared two markers for
germ cells to identify oocytes. Although several germ cell
markers have been identified, only two, Germ Cell Nuclear
Antigen-1 (GCNA-1) and MVH, are expressed in oocytes
through fetal to early postnatal life (Enders and May, 1994;
Fujiwara et al., 1994; Pesce et al., 1998; Toyooka et al.,
2000). A rat monoclonal anti-GCNA-1 antibody has been
raised against enriched mouse pachytene spermatocytes
(Enders and May, 1994). The antigen is expressed specifi-
cally in primordial germ cells upon entry into fetal gonads,
and the expression continues in the developing gonads of
both sexes until late diplotene stage of meiotic prophase
(Wang et al., 1997). The antibody recognizes a heteroge-
neous population of proteins between 80 and 110 kDa in
spermatogenic cells, but the gene encoding the antigen has
yet to be identified. A rabbit polyclonal anti-MVH antibody
has been raised against full-length murine MVH protein, a
member of the DEAD box family of RNA helicases
(Toyooka et al., 2000). The antibody recognizes a single
85-kDa band in adult testis, corresponding to the known
molecular weight of MVH protein (Fujiwara et al., 1994).
Immunohistochemical studies have shown that MVH is
expressed in germ cells upon their interaction with the
somatic cells of gonadal primordia (Toyooka et al., 2000).
The expression in oocytes continues throughout fetal devel-
opment, persisting until the development of primordial fol-
licles (Toyooka et al., 2000; Pepling and Spradling, 2001).
We chose GCNA-1 as an appropriate marker for the present
Fig. 2. Stages of meiotic prophase as identified by SC labeling patterns (B, D, F, H, J, and L) in GCNA-1-labeled cells (A, C, E, G, I, and K) in chromosome
spreading preparations. Scale bar, 10 m. (A, B) Leptotene oocyte at 14.5 dpc is characterized by diffuse fine threadlike SC immunolabeling over the nucleus.
(C, D) Early zygotene oocyte at 15.5 dpc is characterized by apparent thickening of SC labeling at discrete loci (arrow), representing the beginning of
homologous pairing. (E, F) Mid zygotene oocyte at 15.5 dpc is characterized by elongation of the thick SC labeling at the homologous pairing cores (arrows).
(G, H) Mid pachytene oocyte at 18.5 dpc is characterized by the presence of 20 discrete SC labeled threads, representing the homologous pairing along the
entire length. (I, J) Early diplotene oocyte at DOB is characterized by the appearance of “Y”-shaped structures with SC labeling (arrowhead) stretching from
the thick thread (arrow). This feature represents the beginning of dissociation between the homologous pairs. (K, L) GCNA-1-labeled cell at DOB with the
background level of SC immunolabeling, named “complex negative.”
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study after comparing the immunolabeling profiles of both
markers in ovarian sections and in dispersed cell prepara-
tions. Next, we examined whether the GCNA-1-labeled
cells represent oocytes in meiotic prophase by double label-
ing with anti-GCNA-1 and anti-SC antibodies in chromo-
some spreading preparations. The characteristic immunola-
beling pattern with the anti-SC antibody offers a reliable
method for determining the stages of meiotic prophase
(Heyting et al., 1988; Dobson et al., 1994; Schalk et al.,
1998; Amleh et al., 2000). Finally, we counted the numbers
of GCNA-1-labeled cells retained in chromosome spreading
preparations from each pair of ovaries, and estimated the
total number of GCNA-1 labeled cells in each ovary using
the ratio estimation method in histological sections through-
out fetal and neonatal development. The results reveal a
continuous decrease in the oocyte population throughout
meiotic prophase.
Materials and methods
Isolation of ovaries
All animal procedures were performed in accordance
with the Canadian Council on Animal Care and approved by
the McGill University Animal Care Committee. Adult CD-1
males (Charles River Canada, St. Constant, Quebec) were
caged with adult CD-1 females overnight, and the presence
of vaginal plugs was examined the following mornings
between 09:00 and 11:00 for up to 3 days. Females with
vaginal plugs were removed and caged separately until use.
Under the assumption that mating occurred between 00:00
and 02:00, the next midday was defined as 0.5 days post-
coitum (dpc). Pregnant females were sacrificed by cervical
dislocation between 13.5 and 18.5 dpc, and their fetuses
were removed from the uterine horns. Ovaries were re-
moved from the fetuses and freed from the surrounding
tissue in Minimal Essential Medium containing Hank’s salts
and 25 mM Hepes buffer (MEM [H]) (Gibco Invitrogen
Corporation, Burlington, ON) under a dissecting micro-
scope (Wild, Heerburg, Switzerland). Neonatal ovaries
were similarly obtained from the litters delivered by preg-
nant CD-1 females. As pups were born on 19.5 dpc, this day
was defined as day of birth (DOB), and the following day
was defined as 1 day postpartum (dpp). Neonatal ovaries
were collected from DOB to 3 dpp. The isolated ovaries
were either immediately fixed for paraffin embedding or
processed for chromosome spreading and/or dispersed cell
preparations.
Histological preparations
Ovaries were fixed in a 3:1 fresh mixture of absolute
ethanol and acetic acid for 1 h at room temperature (RT),
rinsed, and stored in 70% ethanol at 4°C until embedding.
Tissues were dehydrated through gradient concentrations of
ethanol and toluene at RT. Tissues were then infiltrated in a
mixture of 1:1 toluene and melted paraffin (Paraplast Plus,
Fisher Scientific Canada, Montreal, Quebec), followed by
two changes in paraffin alone at 60°C. The tissues were
finally embedded in melted paraffin, and the paraffine
blocks were stored at 4°C. The entire ovary embedded in
paraffin was sectioned at 5 m thickness. For GCNA-1
labeling, 10 sequential sections were placed on each micro-
scope slide (VWR Scientific, West Chester, PA). For
GCNA-1 and MVH parallel labeling, sequential sections
were alternated between two slides.
Preparation of dispersed cells and chromosome spreading
The conventional method to prepare chromosome
spreading from fetal ovaries has been described previously
(Amleh et al., 2000). A cytospin centrifugation step was
introduced when the cell suspension was applied to histo-
logical slides and carried out according to the manufactur-
er’s instruction (Thermo IEC, Needham Heights, MA).
Briefly, the bottoms of cytospin chambers were coated with
vacuum grease (Dow Corning, Midland, MI) and placed on
positively charged histology slides (Fisher Scientific
Canada). A total of 400 l of 0.5% hypotonic NaCl solution
(pH 8.2) was added to each chamber, and the cell suspen-
sion was dropped onto the top. The cells in chambers were
allowed to settle for 5 min at RT, and then centrifuged for
5 min at 500g at RT. The supernatant was aspirated out of
the chambers, and 200 l of 2% paraformaldehyde (pH 8.2)
was added to each chamber. The chambers were centrifuged
for 30 s at 100g at RT. This process was repeated once more
with fixative and three times for washing with 0.4% Photo-
Flo (Kodak Canada, Toronto, ON) (pH 8.0). The slides were
removed from the chambers, air-dried under vacuum for 10
min, and either processed immediately for immunocyto-
chemistry, or stored in an airtight container with silica gel at
20°C for subsequent use.
As the hypotonic treatment and subsequent centrifuga-
tion usually disrupted the cell membrane, a modification
was introduced to preserve the cytoplasmic structures for
double labeling of MVH and GCNA-1. The method for
preparing cell suspensions was identical to that described
for the conventional method. After the final centrifugation,
the cells were resuspended in 200 l of 2% paraformalde-
hyde in PBS (pH 7.6). After 10 s of gentle pipetting, the
cells were centrifuged for 3 min at 380g at RT. This fixation
process was repeated once more. The cells were then resus-
pended in 16 l of PBS, and added directly to histology
slides under chambers and centrifuged, followed by three
times washings as described above.
Fluorescent immunocytochemical labeling
Histological sections on slides were deparaffinized by
toluene and rehydrated through decreasing concentrations
of ethanol. The deparaffinized slides as well as the slides
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with chromosome spreading were washed three times each
for 10 min in the Antibody Dilution Buffer (ADB) contain-
ing PBS (pH 7.6), 1% normal goat serum (Gibco Invitrogen
Corporation, Groningen, the Netherlands), 0.3% bovine se-
rum albumin, and 0.005% Triton X-100 (both Sigma-Al-
drich Canada, Oakville, ON). The slides were then incu-
bated overnight in a humid chamber at RT with the rat IgM
monoclonal anti-GCNA-1 antibody at a concentration of
1:50 and the rabbit anti-SC (or anti-MVH) antibody at a
concentration of 1:1000, diluted in ADB. The next day, the
slides were washed in ADB (3  10 min) and incubated for
45 min with the goat anti-rat IgM fluorescein isothiocyanate
(FITC) conjugated (Pierce Endogen, Rockford, IL) and the
goat anti-rabbit IgG biotin conjugated (Pierce Endogen),
both diluted to 1:1000 in ADB. The slides were washed in
ADB (3  10 min) and incubated for 30 min with the avidin
-Cy3 conjugated (Pierce Endogen) at a final concentration
of 1:1000 in ADB. The slides were washed in PBS (3  10
min), followed by double distilled water (2  2 min), and
air-dried under vacuum for 10 min. The slides were
mounted in the Prolong Antifade mounting medium pre-
pared according to the manufacturer’s instruction (Molecu-
lar Probes, Eugene, OR) and supplemented with 0.4 g/mL
4,6-diamidine-2-phenylindole dihydrochloride (DAPI)
(Boehringer Mannheim, Germany). All slides were exam-
ined under a fluorescence microscope (Zeiss Axiophot, Ger-
many). Immunocytochemical controls were performed in
parallel by processing slides as described above with the
omission of primary antibodies. In addition, the absence of
cross-reactivity of the secondary antibodies was verified by
incubating the slides with the noncorresponding secondary
antibodies. All images were captured with a digital camera
(Retiga 1300, QImaging, Burnaby, BC) and processed with
Northern Eclipse digital imaging software, version 6.0 (Em-
pix Imaging, Mississauga, ON) on an IBM compatible com-
puter. Acquired images were further processed with Adobe
Photoshop version 6.0 (Adobe Systems Inc., San Jose, CA).
The rat monoclonal anti-GCNA-1 antibody was a gift
from Dr. G. Enders, University of Kansas, Kansas City, KS
(Enders and May, 1994). The rabbit polyclonal anti-MVH
antibody was a gift from Dr. T. Noce, Mitsubishi-Kasei
Institute of Life Sciences, Tokyo, Japan (Toyooka et al.,
2000). The rabbit polyclonal anti-SC antibody was a gift
from Dr. P. Moens, York University, Toronto, ON (Dobson
et al., 1994).
Counting of GCNA-1-immunolabeled cells in chromosome
spreading preparations
The total number of GCNA-1-labeled cells retained on a
slide was counted under a microscope at a low magnifica-
tion (200). With the conventional method, two or three
pairs of ovaries were examined from two litters at each
gestation age. With the cytospin method, a total of six pairs
of ovaries were examined from a minimum of two litters at
each gestation age.
The proportions of GCNA-1-labeled cells in meiotic
prophase stages were determined in representative fields of
slides with chromosome spreading prepared by the cytospin
method. The area containing cells on each slide was divided
into 4 quadrants, in each of which the fields of view were
arbitrarily chosen. All GCNA-1-labeled cells in a selected
field were counted and assessed for their SC immunolabel-
ing profiles at a higher magnification (400 and 1000). The
counting was continued until a minimum of 25 GCNA-1-
labeled cells was scored in each quadrant, and thus over 100
cells per pair of ovaries. The meiotic prophase stages were
determined by characteristic patterns of SC immunolabel-
ing. The percentages of individual meiotic prophase stages
were averaged among 6 pairs of ovaries at each gestation
age.
Immunolabeling of GCNA-1 in histological sections
Slides were deparaffinized and incubated with the rat
monoclonal anti-GCNA-1 antibody overnight, followed by
the goat anti-rat IgM biotin conjugated, as described above.
After washings, the slides were incubated for 30 min at RT
with the avidin–biotin–horseradish–peroxidase complex
according to the manufacturer’s instruction (ABC Vec-
tastain Kit, Vector Laboratories, Burlingame, CA). After
washings in PBS (3 10 min), the slides were incubated for
6 min in a solution of 0.02% 33-diaminobenzidine (DAB)
and 0.005% H2O2 in 0.05 M Tris buffer, pH 7.5 (Sigma-
Aldrich Canada), and rinsed in PBS. The slides were then
dehydrated through gradient concentrations of ethanol,
cleared in toluene, and mounted in Permount mounting
medium (Fisher Scientific Canada). Immunocytochemical
controls were performed in parallel by processing slides as
described above with omission of the anti-GCNA-1 anti-
body. The slides were observed under a light microscope
(Zeiss Axiophot).
Estimation of the total number of GCNA-1-immunolabeled
cells per ovary in histological sections
The ratio estimation method (Levy and Lemeshow,
1999) with modifications was used to obtain the total num-
ber of GCNA-1-labeled cells in the ovary. All labeled cells
were counted in randomly selected sections representing
approximately 10% (5–7 sections) of each ovary. Random
numbers were generated with Microsoft Excel 97 (Mi-
crosoft Corporation, Seattle, WA). The picture of the entire
ovary section at low magnification (200) was captured
with a digital camera (Retiga 1300, QImaging), and all
GCNA-1-labeled cells in the section were counted with the
manual count application on Northern Eclipse imaging soft-
ware, version 6.0 (Empix). The area of the section was also
measured from the digital image with the area measurement
application in Northern Eclipse imaging software. From
these values, the average number of GCNA-1-labeled cells
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to area ratio was calculated. This ratio was multiplied by a
calculated estimate of the total ovary area. To estimate the
total ovary area, the area of every fifth section was mea-
sured, the mean section area was calculated, and multiplied
by the total number of sections cut from the ovary. The
average number of GCNA-1-labeled cells per unit area was
multiplied by total ovary area to give an estimate assuming
that all germ cells are equal in size. A correction factor was
introduced to take the change in the germ cell nuclear size
throughout gestation into account. To generate the correc-
tion factor, 20 GCNA-1-labeled cells were randomly se-
lected in a randomly selected section from each ovary, and
their mean nuclear diameters were determined by taking 2
separate measurements in each cell with the line measure-
ment application in Northern Eclipse imaging software. The
mean nuclear diameter per ovary was calculated and aver-
aged at each gestation age. These values were divided by 5
m, the thickness of each section, to generate the correction
factor for each gestation age. The total number of GCNA-
1-labeled cells was divided by the corresponding correction
factor to obtain the true estimate: Yˆ   y /a A/F, where:
Yˆ  total number of GCNA-1 labeled cells in an ovary; y 
yi /n; a  ai /n; yi  total number of GCNA-1 labeled
cells in ith section; ai  area of i th section; n  number of
sections counted per ovary; A  estimated total area of an
ovary; F  correction factor.
To evaluate the precision of the estimates obtained from
5–7 sections of each ovary, we performed metanalyses by
recalculating the estimates separately using either 3 or one
randomly selected sections from each ovary. In both the
main experiment and the metanalyses, 4 ovaries from 4
fetuses from a minimum of 2 litters were examined at each
gestation age.
Statistics
Significant differences in the numbers of GCNA-1-la-
beled cells between gestation ages were assessed by using
the Tukey test for multiple pairwise comparisons. All sta-
tistical analyses, including mean calculations, were carried
out with SYSTAT 9, while SigmaPlot 2000 was used for
data presentation (SPSS Science, Chicago, IL).
Results
Comparison of GCNA-1 and MVH immunolabeling in
ovaries
Immunolabeling patterns of GCNA-1 and MVH were
compared in adjacent sections of ovaries at 15.5 dpc and
DOB. Two ovaries from two fetuses from two litters were
examined at each gestation age. Biotin–avidin amplification
was necessary to obtain labeling with either antibody, and
therefore simultaneous detection of the two antigens in the
same section was not possible. GCNA-1- and MVH-labeled
cells were seen distributed in comparable areas of ovaries.
At 15.5 dpc, the labeled cells were distributed evenly
throughout the ovary (data not shown), while at DOB they
were concentrated in the periphery and scarce in the central
region (Fig. 1A and D). No immunolabeling with either
antibody was seen in the adjacent mesonephros (data not
shown).
At both gestational ages examined, GCNA-1 immunola-
beling was localized in the nuclei of a select population of
cells, most of which showed the characteristics of the oocyte
with spherical shape, large size, and prominent nucleoli
Fig. 3. Progress of meiotic prophase in GCNA-1-labeled cells. Each meiotic prophase stage represents the proportion of total cells (mean 	 SEM) obtained
from six pairs of ovaries from two litters at each gestation age.
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(Fig. 1B and C). All cells morphologically identified as
oocytes with DAPI staining were labeled with the anti-
GCNA-1 antibody. In contrast, MVH immunolabeling was
seen throughout the cytoplasm of a select population of
cells, while it was absent in nuclei as determined by DAPI
staining (Fig. 1E and F). All cells morphologically identi-
fied as oocytes, again with DAPI staining, were labeled with
the anti-MVH antibody. Some cells showed uniform immu-
nolabeling with no corresponding DAPI staining. These
were most likely oocytes whose nuclei did not pass through
the plane of section. It must be noted that some cells were
labeled with either antibody, although they did not show
morphological characteristics of oocytes.
Simultaneous immunolabeling with anti-GCNA-1 and
anti-MVH antibodies was possible in dispersed ovarian
cells since the signal with the anti-GCNA-1 antibody was
sufficiently strong without biotin–avidin amplification. The
same cell population was labeled with both antibodies,
GCNA-1 labeling in the nucleus and MVH labeling in the
cytoplasm (Fig. 1G–L). Many cells were faintly labeled
with the anti-MVH antibody in the nucleus (Fig. 1H) that
was identified by DAPI staining (data not shown) but not in
the cytoplasm. None of these cells displayed GCNA-1 la-
beling. This staining was considered to be nonspecific bind-
ing of the anti-MVH antibody in the nucleus of somatic
cells.
In all above experiments, ovarian sections or cells incu-
bated in the absence of primary antibodies exhibited no
detectable immunolabeling. Similarly, ovarian slides incu-
bated with noncorresponding secondary antibodies exhib-
ited no detectable immunolabeling (data not shown).
Identification of meiotic prophase stages in
GCNA-1-labeled cells
We examined whether GCNA-1-positive cells pro-
gressed in meiotic prophase during ovarian development by
simultaneous labeling with the anti-SC antibody in chromo-
some spreading preparations. The conventional method
yielded a small number of GCNA-1-labeled cells, often
fewer than 100, retained on a histological slide. Accord-
ingly, we introduced a cytospin centrifugation step. The
numbers of GCNA-1-labeled cells retained on slides in-
creased nearly 10-fold at all gestation ages examined (
15.5, 16.5, 17.5, and 18.5 dpc) (data not shown). This
increase in cell retention greatly facilitated the assay as
sufficient numbers of GCNA-1-labeled cells were available
in all slides prepared.
Stages of meiotic prophase in GCNA-1-labeled cells
were identified by the characteristic patterns of SC labeling
(Fig. 2). Leptotene was characterized by diffuse fine thread-
like SC immunolabeling throughout the nucleus (Fig. 2B).
Early zygotene was characterized by apparent thickening of
the threads at discrete loci in the nucleus (Fig. 2D). By mid
zygotene, the threads became continuous and fewer in num-
ber, but their entire lengths were longer (Fig. 2F). Pachytene
was characterized by the presence of 20 discrete threads
representing the pairing cores between homologous chro-
mosomes along their entire length (Fig. 2H). Early diplotene
was characterized by the appearance of “Y”-shaped or
looped SC labeled threads (Fig. 2J). At all stages examined
(13.5 to 3 dpp), a population of GCNA-1-labeled cells
Fig. 4. The total number of GCNA-1-labeled cells recovered from each pair of ovaries by cytospin centrifugation. Each point represents the mean 	 SEM
obtained from six pairs of ovaries from two litters. Significant decreases are found between 13.5 and 14.5 dpc, between 15.5 and 16.5 dpc, and between DOB
and 1 dpp (*, P 
 0.05).
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showed no detectable SC labeling (Fig. 1L). We named this
population “complex negative.”
The proportions of GCNA-1-labeled cells at individual
meiotic prophase stages were estimated throughout the ges-
tation ages from 13.5 to 3 dpp (Fig. 3). A small population
of leptotene oocytes was observed at 13.5 dpc. This popu-
lation peaked at 14.5 dpc and disappeared by 17.5 dpc,
although a small population (3%) reappeared at 18.5 dpc.
Zygotene oocytes appeared at 14.5 dpc and peaked at 15.5
dpc. This population persisted and fluctuated between 15.5
and 18.5 dpc and then disappeared by DOB. Pachytene
oocytes appeared at 15.5 dpc, and continuously increased to
a peak at 17.5 dpc. This population remained elevated until
DOB, suddenly dropped to almost none by 1 dpp. Early
diplotene oocytes appeared at DOB, peaked at 1 dpp, and
declined thereafter. Complex negative oocytes were present
at all stages examined. This population was high at 13.5 dpc
and rapidly declined with further gestation ages. The pop-
ulation remained low between 15.5 and 18.5 dpc, and then
increased thereafter. Few, if any, GCNA-1-negative cells
were immunolabeled with the anti-SC antibody.
Changes in the total number of GCNA-1-labeled cells
during ovarian development
We estimated the total number of GCNA-1-labeled cells
in the chromosome spreading preparation obtained from
each pair of ovaries through 13.5 dpc to 3 dpp (Fig. 4).
There was a continuous decline in the average number of
GCNA-1-labeled cells from 2900 at 13.5 dpc to 250 at 3
dpp. Significant decreases (P 
 0.05) were found between
13.5 and 14.5 dpc, between 15.5 and 16.5 dpc, and between
DOB and 1 dpp.
To verify the biological validity of the decline in the
GCNA-1-labeled cell population during fetal development
observed in chromosome spreading preparations, we esti-
mated the total number of GCNA-1-labeled cells in the
ovary by using the ratio estimation method in histological
sections. Changes in the distribution of GCNA-1-labeled
cells during ovarian development were apparent upon in-
spection of histological sections (Fig. 5). At 13.5 dpc,
GCNA-1-labeled cells were small in nuclear diameter and
clustered throughout the ovary (Fig. 5A). At 15.5 dpc,
GCNA-1-labeled cells were still distributed over the ovary;
however, they appeared to have larger nuclear diameters
and were clustered in larger groups near the periphery (Fig.
5B). At 17.5 dpc, GCNA-1-labeled cells were concentrated
toward the periphery, while the size of cell clustering de-
creased (Fig. 5C). Single cells were more frequently seen in
the center. At DOB, the distribution of GCNA-1-labeled
cells was similar to that seen at 17.5 dpc; however, the space
between the labeled cells appeared to have increased (Fig.
5D). At 2 dpp, GCNA-1-labeled cells were scarce in the
center, and the space between the labeled cells appeared to
have further increased in the periphery (Fig. 5E).
The measurements made for estimation of the total num-
ber of GCNA-1-labeled cells in the ovary are given in Table
1. The average total area of the ovary increased continu-
ously during development with significant differences be-
tween 13.5 and 17.5 dpc, as well as between 15.5 dpc and
DOB. Meanwhile, the germ cell number per unit area
steadily decreased, with significant differences between
15.5 and 17.5 dpc and between 17.5 dpc and DOB. The
mean germ cell nuclear diameter increased significantly
between 13.5 and 15.5 dpc, as well as between 15.5 and
17.5 dpc.
The final estimates are summarized in Fig. 6A. A steady
decrease in the total number of GCNA-1-labeled cells was
observed with significant differences at every 2-day interval
between 13.5 dpc and DOB (P 
 0.05). The total number of
GCNA-1-labeled cells estimated per ovary ranged from
21171 	 673 at 13.5 dpc to 7226 	 320 at 2 dpp.
To assess the precision of the estimates obtained from
5–7 randomly selected sections per ovary, the estimates
were made similarly but using 3 randomly selected sections
or 1 randomly selected section per ovary. Using 3 randomly
selected sections per ovary, a constant decrease in the total
number of GCNA-1-labeled cells during development was
observed (Fig. 6B), similar to the observation made with
5–7 sections per ovary (Fig. 6A). However, significant de-
creases were found only between 15.5 and 17.5 dpc and
between 17.5 dpc and 2 dpp. The total number of GCNA-
1-labeled cells per ovary ranged from 20,509 	 881 at 13.5
dpc to 7688 	 350 at 2 dpp, which are close to the values
obtained with 5–7 sections per ovary. An overall decrease in
the number of GCNA-1-labeled cells was also observed
when only 1 randomly selected section per ovary was used
for estimation (Fig. 6C). The number of GCNA-1-labeled
cells estimated per ovary ranged from 19,966 	 1072 at
13.5 dpc to 7530 	 1466 at 2 dpp, which are in the same
range as when multiple sections were counted per ovary.
However, a significant decrease was observed only between
15.5 and 17.5 dpc, and no loss was found between 13.5 and
15.5 dpc or between 17.5 dpc and 2 dpp.
Discussion
GCNA-1 has advantages as a germ cell marker
Accurate counting of oocytes largely depends on the
method used to identify oocytes. Use of biochemical markers
is desirable since morphological criteria at the light micro-
scope level are questionable. Indeed, the use of morphology
alone to identify oocytes has been pointed out as a potential
shortcoming in the previous studies (Baker, 1963; Beau-
mont and Mandl, 1962). Electron microscopy, while more
reliable than light microscopy for defining oocytes, is inad-
equate for quantification. Despite an abundance of markers
for primordial germ cells, very few remain expressed in
germ cells throughout ovarian development. Of these, two
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antigens, GCNA-1 and MVH, are known to be expressed in
oocytes throughout the meiotic prophase (Enders and May,
1994; Toyooka et al., 2000).
In the present study, we compared the immunolabeling
patterns of GCNA-1 and MVH in both dispersed cells and
histological sections from fetal and neonatal mouse ovaries.
All cells labeled for GCNA-1 were also labeled for MVH in
ovarian cell suspensions, and a similar population of cells
with the characteristics of oocytes was labeled for either
antigen in adjacent tissue sections. We conclude that the two
markers label the identical population of germ cells. How-
ever, we chose GCNA-1 as a better marker for counting
oocytes because of its nuclear localization, which was easy
to distinguish in both histological sections and ovarian cell
suspensions. In contrast, the cytoplasmic labeling of MVH
was prone to repeat counting of the same cells, and correc-
tion for the increase in oocyte size during ovarian develop-
ment would have been difficult. Furthermore, hypotonic
NaCl treatment of cell suspensions, which was necessary for
visualizing SC immunolabeling patterns, destroyed the cy-
toplasmic integrity of most cells and thus limited the use of
MVH immunolabeling.
GCNA-1-labeled cells represent the oocytes that go
through meiotic prophase
Simultaneous labeling of GCNA-1 and SC in chromo-
some spreading preparations revealed that the majority of
GCNA-1-labeled cells entered meiosis and progressed
through meiotic prophase. The onset as well as the duration
of each stage in gestation days corresponded well with those
reported in earlier studies (Borum, 1961; Bakken and Mc-
Clanahan, 1978; Speed, 1982; Dietrich and Mulder, 1983).
However, a population of GCNA-1-labeled cells without
SC immunolabeling was seen throughout the gestation pe-
riod examined. This population, termed “complex nega-
tive,” was high at earlier gestation ages, notably at 13.5 and
14.5 dpc, when most germ cells had yet to enter into mei-
osis. The majority of these cells are most likely oogonia.
Such a “complex negative” cell population decreased rap-
idly with gestation ages and reached the lowest (
20%) at
18.5 dpc, indicating that the majority of GCNA-1-labeled
cells had entered into meiosis. The “complex negative”
population increased again at later gestation ages, when
synaptonemal complexes began to dissolve as oocytes
reached the diplotene stage.
It is unlikely that the small population of “complex
negative” GCNA-1-labeled cells observed at 16.5–18.5 dpc
entered into meiosis at later developmental stages. First,
premeiotic DNA synthesis has been reported to end by
14.5–15.5 dpc in the mouse (Lima-De-Faria and Borum,
1962; Crone et al., 1965; Park and Taketo, unpublished
observations). Second, if the GCNA-1-labeled cells were to
enter into meiosis at later gestation ages, early meiotic
prophase stages would have persisted throughout our pro-
file. This was not observed as leptotene disappeared by 17.5
dpc and zygotene by 18.5 dpc. It is also unlikely that these
cells had arrested at early leptotene, which was barely labeled
for SC, and resumed meiotic prophase later on since zygo-
tene or pachytene oocytes were not observed after 18.5 dpc.
The “complex negative” GCNA-1-labeled cells observed
at 16.5–18.5 dpc may correspond to a population of oogonia
arrested in mitosis, which has been recently reported
(Wartenburg et al., 2001). Interestingly, these germ cells,
maintaining metaphase-like chromosomes but lacking visi-
ble spindles, persist without apparent signs of degeneration
for as long as 3 days. Assuming that the last premeiotic
S-phase occurs at 15.5 dpc, oogonia arrested in mitosis may
be seen until 18.5 dpc, as observed in our present studies.
The proportion of “arrested oogonia” within the total pop-
ulation of germ cells was not examined in the previous
study. Our results suggest that the population of arrested
oogonia may be contributing to a significant part of the
germ cell loss. We have not excluded other possibilities. For
Table 1
Measurements in histological sections of ovaries
Gestation age
(dpc/dpp)
Total ovary area
(mm2)*
GC nuclear diameter
(m)*
GC number per unit area
(m2)*
Correction
factor**
13.5 0.392 	 0.025 3.84 	 0.11 0.0420 	 0.0029 0.77
15.5 0.469 	 0.033 4.84 	 0.19c 0.0366 	 0.0019 0.97
17.5 0.554 	 0.036a 5.84 	 0.06d 0.0278 	 0.0015e 1.17
DOB 0.660 	 0.056b 5.92 	 0.09 0.0178 	 0.0006f 1.18
1 0.739 	 0.025 6.08 	 0.13 0.0133 	 0.0006 1.22
* Values are expressed as mean 	 SEM.
** Correction factor equals mean germ cell (GC) nuclear diameter over 5 m, thickness of the ovary section.
a The increase in total ovary area between 13.5 and 17.5 dpc is significant, P 
 0.05.
b The increase in total ovary area between 15.5 dpc and DOB is significant, P 
 0.05.
c The increase in GC nuclear diameter between 13.5 and 15.5 dpc is significant, P 
 0.05.
d The increase in GC nuclear diameter between 15.5 and 17.5 dpc is significant, P 
 0.05.
e The decrease in GC number per unit area between 15.5 and 17.5 dpc is significant, P 
 0.05.
f The decrease in GC number per unit area between 17.5 dpc and DOB is significant, P 
 0.05.
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example, the “complex negative” GCNA-1-labeled cells
may have lost SC antigenicity during cell preparations or
represent oocytes undergoing degeneration. Further studies
are needed to determine the nature of “complex negative”
GCNA-1-labeled cells.
Continuous loss of oocytes during fetal development
The total number of GCNA-1-labeled cells counted in
the chromosome spreading preparations indicated a contin-
uous loss of germ cells during fetal development. Signifi-
cant losses were found between 13.5 and 14.5 dpc, between
15.5 and 16.5 dpc, and between DOB and 1 dpp. These
periods correspond to the peak of premeiotic S-phase, the
peak of zygotene, and the end of pachytene, respectively.
These observations do not support the hypothesis that errors
in homologous pairing is the major cause of oocyte loss
during meiotic prophase (Speed, 1982). However, the chro-
mosome spreading method used in this study has a technical
limitation. Although introduction of a cytospin centrifuga-
tion step significantly improved cell retention on slides, the
total numbers of GCNA-1-labeled cells counted were far
smaller than those previously reported (Tam and Snow,
1981; Jones and Krohn, 1961) or estimated by us in histo-
Fig. 5. GCNA-1 labeling in histological sections of fetal (A–C) and neonatal (D, E) ovaries. Scale bar, 250 m. (A) Mid section of an ovary at 13.5 dpc.
The labeled cells are uniformly distributed throughout the ovary. Note the small nuclear diameters and frequent clustering (arrowhead) of the labeled cells.
(B) Mid section of an ovary at 15.5 dpc. The labeled cells are distributed throughout the ovary. Note the increased nuclear diameter and larger clustering
of labeled cells in the periphery as compared to the section in (A). (C) Mid section in an ovary at 17.5 dpc. The labeled cells are concentrated in the periphery
and fewer in the central region. Note less clustering of labeled cells compared with the section in (B). (D) Mid section of an ovary at DOB. Note fewer
clustering and increase in the space between the labeled cells in the periphery. (E) Mid section of an ovary at 2 dpp. The labeled cells are seen almost
exclusively in the periphery. Note the further increased space between the labeled cells.
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logical sections. There seemed to be an apparent loss of
cells during the isolation process. Furthermore, the loss
appears to be exacerbated at later gestation ages if compared
with the loss estimated in histological sections. It is con-
ceivable that the oocytes in later stages of meiotic prophase,
probably due to their larger sizes, may be more vulnerable
to mechanical dissociation or more adhesive to plasticware.
Nonetheless, we believe that our results of cytospin chro-
mosome spreading method represent the oocyte population
in vivo since the progress and duration of meiotic prophase
stages are consistent with the previous reports using histo-
logical sections (Borum, 1961; Bakken and McClanahan,
1978; Speed, 1982).
We attempted to make an accurate estimate of the num-
ber of germ cells in the ovary by counting the GCNA-1-
labeled cells in histological sections and calculating based
on the ratio estimation model. We randomly selected sec-
tions from each ovary. This is important as it eliminates the
possibility of bias when sections are chosen at a particular
position or arbitrarily. In addition, we counted multiple
sections from each ovary. This increased the accuracy, as
discussed below. We also took into consideration the find-
ing that the average germ cell nuclear diameter increased
with gestation ages. If we were to simply calculate the total
number of germ cells based on the number per section and
total ovary area, the estimates would have been deflated at
earlier ages since the average nuclear diameter is smaller
than the thickness of one section. As well, the estimates
would have been inflated at later gestation ages since the
average nuclear diameter is larger than the thickness of one
section.
The results from histological sections are consistent with
those obtained with cell suspensions, indicating a continu-
ous loss of germ cells during fetal development. Significant
loss was seen at every 2-day interval examined except for
the period between DOB and 2 dpp. These results agree
with earlier studies (Borum, 1961; Bakken and McClana-
han, 1978; Speed, 1982). Furthermore, we found the loss of
germ cells from 13.5 dpc to DOB to be approximately 65%.
This result is in agreement with the percentage loss ob-
served in the rat and human (Beaumont and Mandl, 1962;
Baker, 1963).
On the other hand, our present results as well as many
previous reports disagree with the study using MVH as a
germ cell marker (Pepling and Spradling, 2000). The latter
authors did not find any loss of oocytes in fetal life but
found a major loss between 1 and 2 dpp. Furthermore, the
total numbers of germ cells estimated, ranging from 6000 at
13.5 dpc to 2000 after birth, are much smaller than the
estimates obtained by others including ourselves. This dis-
crepancy cannot be simply attributed to different markers to
identify oocytes since our results showed that the 2 markers
label identical germ cell populations. Possible recounting of
the same cells due to cytoplasmic labeling may inflate the
estimate but cannot explain the underestimation. Nor can
the discrepancy be explained by differences between mouse
strains as both studies used CD-1 mice. We believe that the
discrepancy arose due to different methods of oocyte count-
ing. Pepling and Spradling counted the total MVH-labeled
cells in a single representative section from each ovary.
Using the average diameter of a germ cell, the fraction of
ovarian volume represented by the counted section was
calculated. This allowed for the computation of the total
number of germ cells in the whole ovary. This counting
method was modified at 21.5 dpc and later to take into
account the differences in germ cell density in the inner and
outer cortex, although no details of the modification were
provided. It must be noted that this gestation age coincides
with the abrupt decrease in the number of oocytes found by
the authors. Also, Burgoyne and Baker (1985) have pointed
out that errors may occur by selecting the area for counting
in perinatal ovaries when the distribution of germ cells is
not random and the oocytes at the diplotene stage vary
enormously in size. We believe that counting all cells in
multiple randomly selected sections gives the best estimate
in such a case.
The number of sections counted per ovary affects the
accuracy
For the sake of accuracy, we counted multiple (5–7)
sections, covering 10% of the total number of sections, from
each ovary. To evaluate the need for such a rigorous count-
ing method to estimate the total germ cell population, we
recalculated the estimates based on three and one randomly
selected section per ovary. The results were similar when
only three sections were counted per ovary. However, sta-
tistical significance was lost at certain points probably as a
result of counting a small number of ovaries. Quite different
results were obtained when only single section was counted
per ovary. Although the overall trend of germ cell loss was
observed and the range of germ cell numbers was similar to
those obtained with multiple sections, no losses were ob-
served at many intervals of ovarian development. These
results further justify the need for counting multiple sections
per ovary.
Conclusions
We have shown that the oocyte population continuously
decreased during meiotic prophase in the mouse ovary. This
observation does not favor any one particular cause of germ
cell elimination. Instead, it suggests the involvement of
multiple causes, probably including the need for trophic
factors, errors in mitosis and chromosome pairing, or telo-
mere defects. The method established here is useful for
identifying the stage of meiotic prophase at which oocytes
undergo major degeneration due to genetic mutations or sex
chromosome anomalies.
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Fig. 6. Changes in the total number of GCNA-1-labeled cells in the ovary during development estimated in histological sections. (A) The number of GCNA-1-labeled
cells counted in 5–7 randomly selected sections from each ovary. Each value represents the mean 	 SEM of 4 ovaries from two litters. Significant decreases are
found in all intervals examined (*, P 
 0.05) except for the interval between DOB and 2 dpp. (B) The number of GCNA-1-labeled cells counted in 3 randomly
selected sections from each ovary. Each value represents the mean 	 SEM of 4 ovaries from two litters. Significant decreases are found between 15.5 and 17.5 dpc
and between 17.5 dpc and 2 dpp (*, P 
 0.05). (C) The number of GCNA-1-labeled cells counted in 1 randomly selected section from each ovary. Each value
represents the mean 	 SEM of 4 ovaries from two litters. Significant decrease is found between 15.5 and 17.5 dpc (*, P 
 0.05).
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